» Articles » PMID: 39695975

Disseminated Cryptococcal Gattii Infection in a Patient with Anti-granulocyte-macrophage Colony-stimulating-factor Autoantibody: a Case Report

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2024 Dec 19
PMID 39695975
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cryptococcosis is an opportunistic fungal infection in immunocompromised patients. The major species include Cryptococcus grubii, Cryptococcus neoformans, and rarely, Cryptococcus gattii. Here we present a disseminated Cryptococcus gattii infection in a patient with elevated granulocyte-macrophage colony-stimulating-factor autoantibody which was successfully treated with antifungal therapy.

Case Presentation: A 61-year-old healthy man presented with a 3-week history of blurred vision, low-grade fever, headache, and a one-year history of low back pain following a fall on his farm. Physical examination revealed lower back tenderness and diplopia. He was tested negative for hepatitis B, C, and human immunodeficiency virus. Chest X-ray revealed a focal opacity in the right retrocardiac paraspinal region and pleural effusion. Magnetic resonance imaging showed a mass located at the L1 prevertebral region and multiple rim-enhancing lesions in bilateral cerebral hemispheres. Thoracoscopy demonstrated cystic lesions at the right costopleural angle. Pathology and microbiology studies confirmed the diagnosis of disseminated Cryptococcus gatti infection. Autoantibodies to granulocyte-macrophage colony-stimulating factor were detected and were considered to cause disseminated cryptococcosis. The patient was started on amphotericin B followed by fluconazole treatment. One month later, the symptoms ameliorated and repeated image studies after 1 year of follow-up showed the resolution of lesions.

Conclusion: This report describes the first case of disseminated Cryptococcus gattii infection involving the musculoskeletal system, respiratory system, and central nervous system with granulocyte-macrophage colony-stimulating-factor autoantibody by evidence of histology and microbiology.

References
1.
Singh N, Sifri C, Silveira F, Miller R, Gregg K, Huprikar S . Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes. Transplantation. 2015; 99(10):2132-41. DOI: 10.1097/TP.0000000000000690. View

2.
Browne S, Burbelo P, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw P . Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012; 367(8):725-34. PMC: 4190026. DOI: 10.1056/NEJMoa1111160. View

3.
Tseng H, Liu C, Ho M, Lu P, Lo H, Lin Y . Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010. PLoS One. 2013; 8(4):e61921. PMC: 3629109. DOI: 10.1371/journal.pone.0061921. View

4.
Guan S, Huang Y, Huang S, Hsiao F, Chen Y . The incidences and clinical outcomes of cryptococcosis in Taiwan: A nationwide, population-based study, 2002-2015. Med Mycol. 2023; 62(1). PMC: 10802930. DOI: 10.1093/mmy/myad125. View

5.
Rosen L, Freeman A, Yang L, Jutivorakool K, Olivier K, Angkasekwinai N . Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol. 2013; 190(8):3959-66. PMC: 3675663. DOI: 10.4049/jimmunol.1202526. View